Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study. - Griffiths EA; Min JS; Lee WN; Yu JC; Patel Y; Myren KJ; Dingli D (Health and quality of life outcomes, 2024)